top of page

nanoparticules

Value-Added Nanotechnology

Pioneer company of nanohybrids for industrial applications

Nano-H, founded in December 2004 by Lyon university researchers, specializes in developing innovative technologies for new materials based on hybrid nanoparticles. The company focuses on functional nanomaterials for optics and tracers, nanomaterials for biological applications, particularly nanodrugs, and chitosan-based hydrogels for biomedical use. Additionally, Nano-H leverages AI to analyze multimineral profiles for innovative diagnostic and prognostic purposes.

Nano-H developed the first hybrid organic/inorganic theranostic drug, AGuIX

Capture d’écran 2022-09-05 à 18.00.03.png
Dossiers de fichiers
PUBLICATIONS

Nano-H has collaborated with numerous companies and academic laboratories on collaborative projects, participating in 17 ANR, European, or other projects as a co-developer or contractor. Its teams and founding members have contributed to over a hundred scientific publications related to Nano-Hybrids.

Capture d’écran 2022-09-07 à 18_edited_e
NANO-H PRODUCTS
Nanohybrid chemistry for tomorrow's applications
11062b_2ebb11c6c0244ffd9cdbae37e7134ba3~
Laboratoire scientifique

ANALYTICAL AND MEDICAL STRATEGY

We offer customized research projects for the academic and industrial sectors. This activity is based on Nano-H's expertise and its ability to adapt its materials to the applications of its customers and partners.

Nano-h is also part of the IMITATE ANR :

Integrated Microsystems for In silico Modeling and in vitro assessment of nanoparticle TrAnsport & radioTherapy Efficacy

TEAM

Nano-H is a company that combines experience and dynamism thanks to  employees of all ages

PARTNERS

Nano-H is participating in the R&D BOOSTER 2019 project - MEDFORCE Project - a development and research project financially supported by the Auvergne-Rhône-Alpes Region.

Need more information?  Contact us :
bottom of page